| 000 | 01727 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514010539.0 | ||
| 264 | 0 | _c20011011 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0091-6749 | ||
| 024 | 7 |
_a10.1067/mai.2001.117591 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhluwalia, P | |
| 245 | 0 | 0 |
_aNedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. _h[electronic resource] |
| 260 |
_bThe Journal of allergy and clinical immunology _cSep 2001 |
||
| 300 |
_a449-54 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aConjunctiva _xchemistry |
| 650 | 0 | 4 |
_aConjunctivitis, Allergic _xdrug therapy |
| 650 | 0 | 4 |
_aE-Selectin _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistamine _xanalysis |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xanalysis |
| 650 | 0 | 4 |
_aLolium _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNedocromil _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 |
_aProstaglandin D2 _xanalysis |
| 650 | 0 | 4 |
_aTears _xchemistry |
| 650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xanalysis |
| 700 | 1 | _aAnderson, D F | |
| 700 | 1 | _aWilson, S J | |
| 700 | 1 | _aMcGill, J I | |
| 700 | 1 | _aChurch, M K | |
| 773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 108 _gno. 3 _gp. 449-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mai.2001.117591 _zAvailable from publisher's website |
| 999 |
_c11468021 _d11468021 |
||